Hair Growth Peptides: The Complete Guide

Hair loss affects approximately 50% of men by age 50 and at least 25% of women, driven by genetics, hormonal shifts (primarily DHT), chronic inflammation, nutritional deficiencies, and scalp aging.  Medical treatments like minoxidil and finasteride are effective, but will require indefinite use and can cause side effects.

How Peptides Stimulate Hair Growth: The 4 Core Mechanisms

Every effective hair growth peptide operates through at least one of four biological pathways. Understanding these mechanisms lets you evaluate any product on scientific rather than marketing terms.

Primary mechanism Supports keratin intermediate filament organization and helps maintain follicular structural integrity.	Secondary mechanism Promotes activation and prolongation of the anagen (growth) phase at the follicle level.
Key amino acids delivered Cysteine, serine, glutamic acid, and methionine — essential amino acids involved in keratin fiber synthesis.	Delivery method Oral capsules or gummies designed for systemic absorption through the digestive system to follicle tissue.

The most effective formulas target multiple mechanisms simultaneously.

The 7 Best Peptides for Hair Growth

Each compound is assessed by volume and quality of clinical evidence, primary mechanism, and relevance to the most common forms of hair loss.

IFP-131™ is OMI’s exclusive Intermediate Filament Peptide (IFP) complex: a proprietary, patent-protected extract of bioactive keratin peptides derived from ethically sourced New Zealand strongwool.  It isn't available in any other product on the market, and it's the only compound in this category with published human clinical trial data specifically studying follicle bond repair as the primary endpoint.

What ‘Intermediate Filament’ Means 

Intermediate filaments are structural proteins that form the internal scaffold of follicle cells, anchoring them to the surrounding dermal tissue and giving each hair strand its tensile strength and elasticity.  When this scaffold degrades through aging, hormonal changes, stress, or pollution, follicles lose their grip.  Hair thins and shedding accelerates.  Most peptides on the market address growth signaling while IFP-131™ addresses the structural foundation that makes growth possible in the first place.

Primary mechanism Supports keratin intermediate filament organization and helps maintain follicular structural integrity.	Secondary mechanism Promotes activation and prolongation of the anagen (growth) phase at the follicle level.
Key amino acids delivered Cysteine, serine, glutamic acid, and methionine — essential amino acids involved in keratin fiber synthesis.	Delivery method Oral capsules or gummies designed for systemic absorption through the digestive system to follicle tissue.

Clinical Results: Published Human Trials

• Significant decrease in hair loss and shedding

• Enhanced strand strength and improved tensile integrity

• Extended hair growth cycles with a higher anagen-to-telogen ratios confirmed by dermatologist imaging

• Increased hair density, shine, volume, and elasticity

• 100% of study participants experienced a measurable improvement at the 90-day mark

• Generally very well tolerated

• Results confirmed by independent imaging and dermatologist assessments

The 3 Published Studies

Publication	Study Focus	Main Findings	Reference
ScientificWorldJournal • 2014	Full Formula Study	Double-blind, placebo-controlled trial showed significant improvements in hair growth, strand strength, and shedding reduction. Results were confirmed with imaging and dermatologist assessment.	Beer C, Wood S, Veghte RH. 2014:641723. doi:10.1155/2014/641723. PMCID: PMC4214097
HealthMED • 2024 • Vol 18, No. 2	Keratin Peptides Study	Human supplementation study found measurable improvements in hair, skin, and nail attributes. 100% of participants reported improvement at 90 days.	Kelly R, et al. HealthMED. 2024, Vol 18, Num 2.
Cosmetics & Toiletries • 2019	Mechanistic Hair Study	Keratin peptide blend was shown to anchor follicles and significantly reduce pollution-induced hair fall. Structural anchoring mechanism confirmed with imaging.	Roddick-Lanzilotta AD, Kelly RJ, et al. Vol 134, No. 9. Pg 24–36. Oct 2019.

Developed in collaboration with Dr. Rob Kelly, a leading authority in regenerative hair science and bioactive hair peptides, and reviewed by OMI’s Scientific Advisory Board including Dr. Antonella Tosti, MD (University of Miami, 800+ scientific publications).

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human plasma and the best-documented individual peptide for hair applications. It has been studied for follicle enlargement, anagen phase extension, DHT suppression, and scalp collagen synthesis.

Primary mechanism Extracellular matrix remodeling and dermal repair through collagen, elastin, and wound-healing signaling.	Secondary mechanism Support of follicular cycling and maintenance of the anagen phase through dermal papilla and Wnt/β-catenin-associated signaling.
Additional action Supports collagen and elastin synthesis within the scalp dermis.

Key evidence: Early human studies using peptide-enhanced delivery systems reported improvements in hair-growth metrics within two months. GHK-Cu was associated with increased follicular activity, support of anagen-phase maintenance, and reduced miniaturization-related changes. A 2018 review in the International Journal of Molecular Sciences summarized evidence supporting its regenerative, tissue-remodeling, and anti-inflammatory effects in skin and scalp tissue.

Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. PMC6073405

Biotinoyl Tripeptide-1 is among the most widely used cosmetic peptides in professional hair serums. Studies suggest it may support dermal papilla activity while strengthening follicular anchoring structures associated with reduced shedding and improved hair retention.

Primary mechanism Dermal papilla cell activation.

Secondary mechanism Follicle-to-dermis anchorage through laminin-5 upregulation.

Key evidence: A 32-participant clinical study evaluated a peptide-based formulation containing Biotinoyl Tripeptide-1 as one of the active ingredients compared against 3% minoxidil over six months. The peptide formula delivered hair-density improvements comparable to minoxidil, while the untreated control group showed no measurable improvement. The study remains one of the most referenced clinical comparisons between a peptide-based hair formula and a pharmaceutical standard.

Loing E, et al. (2013). A new strategy to modulate alopecia using a combination of specific ingredients. J Cosmet Sci. PMC12251978

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protective gastric protein sequence. It's widely discussed in regenerative medicine research for its tissue-repair, anti-inflammatory, and angiogenic properties, which may be relevant to scalp and follicle health.

Primary mechanism Anti-inflammatory signaling support through TNF-α and IL-6 modulation.	Secondary mechanism Angiogenic support through VEGF-associated pathways.
Additional action Tissue-repair support around stressed or inflamed follicular tissue.

Key evidence: Preclinical studies demonstrate significant tissue-repair and angiogenic activity across tendon, vascular, and wound-healing models. Human clinical evidence specific to hair growth remains limited. Most regenerative-medicine research involving BPC-157 has utilized injectable administration under clinical supervision.

Chang CH, et al. (2021). The promoting effect of BPC 157 on tendon healing. J Appl Physiol. PMC8275860

Acetyl Tetrapeptide-3 targets the extracellular matrix surrounding the hair follicle, helping support the structural environment associated with sustained hair growth. By promoting key ECM proteins involved in follicular support and adhesion, it's associated with reduced shedding and improved follicle retention. It was one of the active compounds used in the 32-participant minoxidil comparison study.

Primary mechanism Extracellular matrix protein support through collagen IV and fibronectin.

Outcome Reduced shedding and support of follicular anchoring structures.

Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide involved in tissue repair, cellular migration, and regenerative signaling. TB-500 is a synthetic derivative designed for improved systemic bioavailability and is widely discussed in regenerative medicine research for its potential role in recovery from inflammatory or tissue-stress conditions that may affect follicle health.

Primary mechanism Hair follicle stem-cell activation and regenerative signaling.

Secondary mechanism Support of tissue remodeling and anti-fibrotic pathways surrounding follicles.

Philp D, et al. (2004). Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. PMID:14657002

Oligopeptide-2 is an IGF-1–inspired signaling peptide designed to support pathways involved in follicular growth and anagen-phase maintenance. Because reduced IGF-1 activity has been associated with follicle miniaturization and stress-related shedding, it's commonly used in formulations targeting diffuse thinning, post-stress hair changes, and weakened hair quality.

Primary mechanism Support of IGF-1-associated signaling in dermal papilla cells.

Outcome Support of follicular nourishment and maintenance of the anagen growth phase.

Topical vs. Oral vs. Injectable: Choosing the Right Delivery

Oral peptides = systemic delivery to follicle tissue

Oral peptide supplementation works by absorbing bioactive peptides through the digestive system and transporting them systemically to keratin-rich tissues. This approach is particularly well-suited for keratin-derived peptides like IFP-131™, because the target tissue (the follicle bulb and root sheath) is better reached via bloodstream delivery than surface application. Results with OMI Hair Growth Peptides develop progressively over 90 days as the follicle environment improves and new anagen hairs emerge.

Topical peptides = localized scalp delivery

Topical serums and foams containing GHK-Cu, Biotinoyl Tripeptide-1, or Acetyl Tetrapeptide-3 are applied directly to the scalp. Efficacy depends heavily on penetration, most peptides are too large to reach the follicle bulb without delivery enhancement technology (liposomal encapsulation, microneedling pretreatment, or nano-emulsion carriers). Standard leave-on products without such technology yield limited follicular absorption.

Injectable peptides = clinical administration

Injectable protocols, particularly mesotherapy (microinjections into the scalp’s mesoderm layer), bypass the penetration barrier entirely. BPC-157 and Thymosin Beta-4 are most commonly used in injectable protocols. These require clinical administration, carry procedural risks, and are not available OTC. And, most importantly, they're not FDA approved.

The Hair Growth Cycle: Why It Matters for Peptides

Peptides work by influencing the phases of the hair growth cycle. Understanding this cycle helps you interpret results correctly and avoid abandoning an effective protocol too early:

Anagen Growth Phase 85% of follicles active lasts 2–7 years

Catagen Transition 1–2% lasts 2–3 weeks

Telogen Resting 10–15% lasts ~3 months

Normal Shedding 50–100 hairs shed daily is normal

IFP-131™ and other peptides primarily work by extending the anagen phase and improving the anagen-to-telogen ratio — the proportion of follicles in active growth vs. resting. Clinical imaging in IFP-131™ studies confirmed significantly higher anagen-to-telogen ratios in the treatment group vs. placebo, which directly corresponds to thicker, denser hair over time. Because hair grows only 1–1.5 cm per month, these improvements take months to become visible. The 90-day milestone identified in the IFP-131™ clinical data is entirely consistent with this biology.

What to Expect: A Realistic Results Timeline for OMI Hair Growth Peptides with IFP-131™

Weeks 2–4

Scalp condition and hair quality may begin to improve as keratin-supportive peptides help reinforce the follicular environment. Early signs can include reduced fragility, improved texture, and less breakage, consistent with keratin-repair findings reported in clinical studies.

Weeks 5–8

Hair shedding may begin to normalize as follicles maintain a healthier anagen-to-telogen balance. Some users report early visible regrowth around the temples and hairline, along with hair that feels stronger and more resilient.

Day 90 (3 months) — The Clinical Benchmark

100% of trial participants reported a measurable improvement in hair parameters.

Imaging and fiber-analysis studies suggest improvements in follicular activity, hair-shaft quality, and structural integrity This is the minimum evaluation point for any peptide protocol.

Months 4–6

Visible density and fullness typically become more apparent. As additional follicles remain in the growth phase and keratin structure improves, hair may appear thicker, healthier, and more uniform in texture. This is when before/after photography becomes most compelling.

Month 6+

Continued use is generally recommended to support long-term follicular health and hair quality. Keratin peptide systems are intended to support the structural environment surrounding the follicle and hair fiber over time.

Who Benefits Most from Peptide Hair Treatments?

Women experiencing hormonal or age-related thinning: OMI Hair Growth Peptides with IFP-131™ was developed specifically for women and is particularly effective for hormonal shifts, nutritional demands, and when stress compounds.

Early to moderate hair shedding and thinning: Pattern hair loss in its earlier stages responds best. The structural repair and follicle-anchoring mechanisms of IFP-131™ are most effective before significant permanent miniaturization has occurred.

Diffuse shedding and stress-related hair shedding: Post-illness, post-crash diet, or chronic stress-related shedding responds well to the anagen-extension and follicle-nourishing mechanisms of keratin peptide supplementation.

Anyone seeking a drug-free alternative: OMI Hair Growth Peptides with IFP-131™ is completely drug-free, and has no reported significant side effects in clinical trials.

Who It’s Not For

Alopecia areata, scarring alopecias (lichen planopilaris, frontal fibrosing alopecia), and rapid or complete hair loss have autoimmune or fibrotic drivers that require a dermatological evaluation before beginning any peptide or supplement  protocol. Consult your doctor for these conditions.

When to see a specialist first

Alopecia areata, scarring alopecias (lichen planopilaris, frontal fibrosing alopecia), and rapid or complete hair loss have autoimmune or fibrotic drivers that require dermatological evaluation before beginning any supplement protocol.  Consult your doctor  for these conditions.

Ready to experience IFP-131™?

Join the thousands of women who have already experienced real results.

Try IFP-131™ by OMI Today

Clinically studied. Patented. Purposely built for your biology.

Visit omiwellbeauty.com

Frequently Asked Questions

Do hair growth peptides actually work?

Yes, with important context about which compounds and what delivery.  The best-studied peptides have published human clinical data supporting measurable improvements in shedding reduction, strand strength, and density improvements. OMI Hair Growth Peptides with IFP-131™ has three published studies showing 100% of participants experienced measurable improvement at 90 days.

How long do hair growth peptides take to work?

Expect initial shedding reduction by day 90, the clinical benchmark used in published studies.  Full results develop 90 days and after, reflecting the biology of the hair growth cycle.  Do not evaluate any peptide protocol before the 3-month mark.

What is IFP-131™?

IFP-131™ is a proprietary Intermediate Filament Peptide complex, a patented, bioactive keratin peptide extracted from New Zealand strong wool using technology developed by Dr. Rob Kelly. It is the only compound in the hair peptide category with published human clinical data specifically studying follicle bond repair as the primary endpoint, and it is available exclusively in OMI Hair Growth Peptides. Clinical studies published in ScientificWorldJournal (2014), HealthMED (2024), and Cosmetics & Toiletries (2019) confirm significant reductions in shedding, improved strand strength, and longer growth cycles, with 100% of participants showing measurable improvement at 90 days.

What is the best peptide for hair growth?

IFP-131™ is the only compound with clinical evidence for follicle bond repair via oral delivery, and the only one exclusively available in OMI Hair Growth Peptides.  GHK-Cu has the strongest individual evidence base for topical use.  Biotinoyl Tripeptide-1 has the most direct RCT data versus topical minoxidil.

Are hair growth peptides safe?

Topical and oral peptides have excellent safety profiles, they are biomimetic compounds that work with natural biology. IFP-131™ recorded no significant side effects across multiple double-blind, placebo-controlled human trials. Topical peptides have poor penetration. Injectable peptides like BPC-157 and Thymosin Beta-4 are not FDA approved and require careful clinical monitoring. Anyone with a medical condition or taking medications should consult a healthcare professional before beginning any supplement protocol.

Can I combine peptides with Minoxidil or Finasteride?

Generally yes. Peptides and Minoxidil act through different mechanisms and are typically complementary rather than competitive. Always disclose all supplements and medications to your physician before combining treatments.

Does BPC-157 help with hair growth?

BPC-157 has compelling preclinical evidence for tissue repair and angiogenesis (both relevant to follicle health) but human clinical data specific to hair loss remains limited.  Injection of BCP-157 isn’t FDA approved  for hair loss.